“Once people started to get infected and reinfected despite being vaccinated, their interpretation then is this vaccine doesn't work…. But [the COVID-19 vaccine] was never designed, studied, tested, or released to protect against infection.” --Ambassador Deborah Birx, MD
The FDA has approved the latest COVID-19 vaccines by Moderna and Pfizer. However, many individuals are asking if they should get the booster and whether it is safe to do so. To address these concerns about the safety of mRNA technology in vaccines and any potential health issues, such as heart problems, associated with these vaccines, Infection Control Today® reached out again to Ambassador Deborah Birx, MD, a Senior Fellow at George W. Bush Institute in Dallas, Texas.
Concerning safety, Birx said, “Vaccines should only be used for their intended use, and for their studied use, and in this case, [the COVID-19 vaccine] was for protecting against severe disease….Once people started to get infected and reinfected despite being vaccinated, their interpretation then is this vaccine doesn't work…. But [the COVID-19 vaccine] was never designed, studied, tested, or released to protect against infection.” Birx acknowledged the existence of potential side effects with vaccines but emphasized their overall safety, particularly the mRNA) vaccines. She highlighted that the safety of mRNA vaccines is well-established yet noted that personal benefits from vaccination may vary from person to person, underlining the individual nature of its effectiveness.
To answer who be immunized, she said, “People who are at risk for severe disease and hospitalization and death.” However, each individual needs to consider the risks and benefits of getting any vaccine. “Going forward, we need to clearly communicate that the protection against infection is so short-lived with our current COVID-19 vaccines that it is an individual decision to understand whether they [are] susceptible…to severe disease, if sometimes even just weeks or a few months’ protection against infection [is] relevant in their lives. And is that a risk-benefit ratio that they're willing to take?”
Birx further elaborated on the topic of potential health issues, stating, “It's naive for us to say that vaccines have no side effects. We are still mapping side effects to this particular vaccine, and the mRNA vaccine is extraordinarily safe. But that doesn't answer the question, ‘Will I personally benefit?’” That, she said, is up to each individual.
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.
Infection Intel: Revolutionizing Ultrasound Probe Disinfection With Germitec's Chronos
November 19th 2024Learn how Germitec’s Chronos uses patented UV-C technology for high-level disinfection of ultrasound probes in 90 seconds, enhancing infection control, patient safety, and environmental sustainability.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies
The Importance of Hand Hygiene in Clostridioides difficile Reduction
November 18th 2024Clostridioides difficile infections burden US healthcare. Electronic Hand Hygiene Monitoring (EHHMS) systems remind for soap and water. This study evaluates EHHMS effectiveness by comparing C difficile cases in 10 hospitals with CMS data, linking EHHMS use to reduced cases.